Literature DB >> 7043053

Plasma aldosterone concentrations in chronic renal disease.

R J Hené, P Boer, H A Koomans, E J Mees.   

Abstract

The disagreement in the literature concerning the role of aldosterone in the maintenance of potassium homeostasis in chronic renal disease might be partially explained by differences in plasma renin activity (PRA) among individual patients. Therefore, a study was done in 28 selected patients with varying degrees of renal insufficiency whose serum potassium and PRA concentrations were within the normal range. The results indicate that at comparable serum potassium and PRA concentrations, plasma aldosterone is in most instances elevated when creatinine clearance is lower than 50% of normal.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7043053     DOI： 10.1038/ki.1982.14

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  46 in total

Review 1.  Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.

Authors:  Miki Nagase
Journal:  Clin Exp Nephrol       Date:  2010-06-09       Impact factor: 2.801

2.  SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling.

Authors:  Jakob Voelkl; Trang Td Luong; Rashad Tuffaha; Katharina Musculus; Tilman Auer; Xiaoming Lian; Christoph Daniel; Daniel Zickler; Beate Boehme; Michael Sacherer; Bernhard Metzler; Dietmar Kuhl; Maik Gollasch; Kerstin Amann; Dominik N Müller; Burkert Pieske; Florian Lang; Ioana Alesutan
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

3.  Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease.

Authors:  Giuseppe Mulè; Emilio Nardi; Laura Guarino; Valentina Cacciatore; Giulio Geraci; Ilenia Calcaterra; Bruno Oddo; Francesco Vaccaro; Santina Cottone
Journal:  Hypertens Res       Date:  2015-01-08       Impact factor: 3.872

4.  Ginsenoside Rg1 protects mouse podocytes from aldosterone-induced injury in vitro.

Authors:  Nan Mao; Yuan Cheng; Xin-li Shi; Li Wang; Ji Wen; Qiong Zhang; Qiong-dan Hu; Jun-ming Fan
Journal:  Acta Pharmacol Sin       Date:  2014-03-17       Impact factor: 6.150

Review 5.  Aldosterone in the pathogenesis of chronic kidney disease and proteinuria.

Authors:  Yee Lu; Elaine Ku; Vito M Campese
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 6.  ACE inhibitors and the kidney. A risk-benefit assessment.

Authors:  G Navis; H J Faber; D de Zeeuw; P E de Jong
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

7.  Role of aldosterone in the remnant kidney model in the rat.

Authors:  E L Greene; S Kren; T H Hostetter
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

8.  Renal potassium excretion: comparison between chronic renal disease patients and old people.

Authors:  C G Musso; R de Miguel; L Algranati; E Dos Ramos Farias
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

9.  Aldosterone activates NF-kappaB in the collecting duct.

Authors:  Valérie Leroy; Sophie De Seigneux; Victor Agassiz; Udo Hasler; Marie-Edith Rafestin-Oblin; Manlio Vinciguerra; Pierre-Yves Martin; Eric Féraille
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

10.  Disordered aldosterone-volume relationship in end-stage kidney disease.

Authors:  Andrew S Bomback; Abhijit V Kshirsagar; Maria E Ferris; Philip J Klemmer
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2009-10-28       Impact factor: 1.636
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.